Fresh analysis reveals that patients who come off blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Published data in a prominent health publication points out that while overweight people can lose substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"People buying these treatments should be cognizant of the potential of rapid weight regain when the medication is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight within about one and a half years.
Weighing Therapies
The study, which examined 37 of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers note that individuals who lose weight through lifestyle changes alone usually see a slower weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Fast Regain
Nutrition scientists suggest the mechanism of the injections is key to understanding the heightened weight return.
These medications imitate a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating a significant risk."
A Chronic Condition?
Health authorities suggest the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, given the likelihood of weight regain, the treatment might need to be long-term.
This view is reinforced by pharmaceutical companies, who note that the findings "emphasize the long-term nature of obesity," similar to managing diseases like hypertension.
Patient Testimonies
Users who have discontinued the jabs explain a powerful return of appetite.
"It was like a switch activating and I was suddenly ravenous," recalled one woman.
This difficulty is compounded if users have not developed sustainable lifestyle or habit changes during therapy.
Significant Adoption
Figures show that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Finally, clinicians stress that while these medications are powerful tools for weight loss, they are not a permanent fix and long-term success likely depends on integrated lifestyle changes.
